Reference
- Brunner H, et al. Safety of adalimumab +/- methotrexate for the treatment of polyarticular juvenile idiopathic arthritis (pJIA): STRIVE registry. Arthritis and Rheumatology 69 (Suppl. 4): abstr. 11, Apr 2017. Available from: URL: http://doi.org/10.1002/art.v69.S4 [abstract] - USA
Copyright information
© Springer International Publishing Switzerland 2017